ARTICLES

Executive of the Year: Arthur Levinson drives Genentech

Biotech's giant moves in: Amgen quietly builds a huge Bay Area operation through acquisitions

Firm turns up pace of business development: Even as big drug makers falter, biotech giant seals dozens of deals a year

Putting his heart into drug development: Thanks to Love, Nuvelo has potential blockbusters

Novartis sends Chiron execs packing: Drug makers sweeps executive suite; deeper cuts on the way

$52M payday for Abgenix brass: Amgen buy presses 'hot button'
 
Inventing a new bio model: Exelixis' financial prowess matches its scientific skills

Production protection: SafeBridge helps ensure drug workers don't suffer from product

Doctors say maggots work magic on wounds: Leeches gaining popularity, too

Businesses crack the code: Bay Area's biggest companies lining up for huge tax breaks

Animal rights 'terror' rattles biotechs' cage

Bay gets short end of terror funding stick:
State gives more to Fresno; feds favor Wyoming

'Underground' squeezes honest firms:

Employer fraud pressures businesses trying to stay legit

UC pays high price for security

Anti-terrorism Inc.:Livermore Lab gets down to the business of security

Just doing their jobs: 200,000 unauthorized workers are crucial to employers Sometimes a watch can be, oh, so much more

Mapping a new plan for biotech


Born to be wild: Racing school helps weekend warriors get their motor running

Wall Street to biotech firms: We don't care

State investigates 'tribal coverage:' Claims workers' comp alternative puts employers at risk

Upward trend: Nonprofit work pays nicely for a handful of executives

Haas and its new dean get used to each other
Tapping into wireless: Breaking in is easy with unprotected network connections all around us

Articles
Biotech Columns
Resume
Awards
The Burrill Report
The Journal of Life Sciences
Podcast
Disgruntled
Click here if you want to contact Daniel S. Levine
 
© Copyright 2004 Daniel S. Levine